| Filed On | Filing |
|---|---|
| 09 Nov 2026 |
8-K: Other Events
Louisville, KY - November 9, 2026 – Humana Inc. (NYSE: HUM) (“Humana”, “we”, or “our”) today announced that it has commenced cash tender offers (collectively, the “Offers”) to purchase the outstanding notes described below, in each case ... |
| 06 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
LOUISVILLE, KY (November 6, 2026) – Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share for the quarter ended September 30, 2026 (3Q26) versus the quarter ended September 30, 2025 (3Q25) and ... |
| 13 Oct 2026 |
8-K: Regulation FD Disclosure
Investors: Lisa Stoner - Humana Investor Relations; (502) 580-2652; |
| 09 Oct 2026 |
8-K: Regulation FD Disclosure
Supplementary audio commentary from Humana’s President and Chief Executive Officer, Jim Rechtin, may be accessed via Humana’s Investor Relations page at https://humana.gcs-web.com/. |
| 01 Sep 2026 |
8-K: Regulation FD Disclosure
Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at various meetings between September 1, 2026 and September 30, 2026. During these meetings, the Company intends to reaffir... |
| 29 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Mark Taylor - Humana Corporate Communications; (317) 753-0345; |
| 29 Jul 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
LOUISVILLE, KY (July 29, 2026) – Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2026 (2Q26) versus the quarter ended June 30, 2025 (2Q25) and for the... |
| 01 Jun 2026 |
8-K: Regulation FD Disclosure
Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at various meetings between June 1, 2026 and June 30, 2026. During these meetings, the Company intends to reaffirm its guid... |
| 19 May 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
Section 2.7. Prohibition of Actions by the Trust and the Trustee 19 |
| 29 Apr 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
LOUISVILLE, KY (April 29, 2026) – Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended March 31, 2026 (1Q26) versus the quarter ended March 31, 2025 (1Q25) as noted... |
| 20 Apr 2026 |
8-K: Submission of Matters to a Vote of Security Holders
The regular annual meeting of the stockholders of Humana Inc. (the “Company”) was held on April 16, 2026 (the “Annual Meeting”), for the purpose of voting on the five (5) proposals detailed in the Company’s Proxy Statement. There were pr... |
| 10 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Mark Taylor - Humana Corporate Communications; (317) 753-0345; |
| 09 Mar 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
Humana Inc., a Delaware corporation (the “Company”), proposes to sell $1,000,000,000 aggregate principal amount of the Company’s 6.625% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056 (the “Notes”). The Notes are to be issued purs... |
| 02 Mar 2026 |
8-K: Regulation FD Disclosure
Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at various meetings between March 2, 2026 and March 31, 2026. During these meetings, the Company intends to reaffirm its gu... |
| 11 Feb 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
LOUISVILLE, KY (February 11, 2026) – Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net (loss) earnings per share (EPS) for the quarter ended December 31, 2025 (4Q25) versus the quarter ended December 31 31, 2024 ... |
| 16 Dec 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Lisa StonerHumana Investor Relations(502) 580-2652e-mail: [email protected] |
| 01 Dec 2025 |
8-K: Regulation FD Disclosure
Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at various meetings between December 1, 2025 and December 31, 2025. During these meetings, the Company intends to reaffirm ... |
| 05 Nov 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Lisa StonerHumana Investor Relations(502) 580-2652e-mail: [email protected] |
| 02 Oct 2025 |
8-K: Regulation FD Disclosure
Supplementary audio commentary from Humana’s President and Chief Executive Officer, Jim Rechtin, may be accessed via Humana’s Investor Relations page at https://humana.gcs-web.com/. |
| 29 Aug 2025 |
8-K: Regulation FD Disclosure
Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at various meetings between September 1, 2025 and September 30, 2025. During these meetings, the Company intends to reaffir... |
Loading...